Up next

Autoplay

Dr. Amaria on Genetically Modified TILs in Melanoma

1 Views • 07/03/23
Share
Embed
administrator
administrator
Subscribers
0

Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay